with significantly higher levels of protein in trisomic than euploid hearts, including myosin regulatory light chain 2 atrial isoform (MLC2a), reticulocalbin, and ezrin. With analysis of protein spots significantly underexpressed in E14.5 trisomic hearts, one significant protein, MLC2v, the ventricular isoform, was identified. MLC2v is a critical component of chamber specification; overexpression could result in abnormal septation, although compensatory action by MLC2a may mitigate this effect. This work represents a novel approach to evaluating the effects of dosage imbalance during development and identified multiple proteins whose abnormal expression levels may disrupt cardiogenesis to produce the pathological conditions in trisomic embryos with cardiovascular defects.
Atrial septation is a critical step in separating the systemic and pulmonary circulations in tetrapods and atrial septal defects are among the most common forms of human congenital heart disease. The canonical view of atrial septation is based on intra-cardiac morphogenetic events, however, recent studies highlight the critical role played by Hedgehog signaling in the second heart field. Here we aim to define the Hedgehog-mediated molecular networks required for atrial septation in the developing mouse embryo using combined genomic approaches. We have developed and validated a microdissection procedure to isolate posterior second heart field (pSHF) tissue. To define Shh dependent transcripts, we have performed transcriptional profiling of pSHFs in wildtype and Shh mutant embryos at E9.5. 146 up-regulated and 124 down-regulated transcripts have been identified, of which 40 have been validated by RT-PCR. Initial expression analysis suggests 4 discrete domains of gene expression in the pSHF: medial mesenchymal, ventral mesenchymal, lateral endodermal, and lateral mesothelial. We interpret these patterns with respect to previous identified functions of the genes analyzed and propose a testable model in which a lateral proliferating population and a ventral-medial differentiating population of cells in the posterior SHF are required for atrial septation. To complement the microarray expression data, we have developed an in-vivo ChIP-seq protocol to identify direct targets of Hh signaling in the pSHF. Expressing the Flagtagged Gli1 or Gli3 transcription factor in the SHF Mef2c lineage, our preliminary Gli:Flag-ChIP data show 8-fold enrichment for a known Gli binding region in the Ptch1 locus. Integrating our gene expression and Gli-binding results will elucidate the Hh-dependent SHF molecular pathways required for atrial septation. Myoblast fusion in the Drosophila embryo initially occurs between founder cells, which pattern the musculature, and fusion competent myoblasts (FCMs). This precursor continues to fuse with additional FCMs until the final myotube size is achieved. Cell surface proteins Sns and Kirre mediate recognition between these two cell types, and are critical in the FCMs and founder cells/developing myotubes, respectively. In contrast to this initial asymmetry, current models for myoblast fusion predict that the bipartite guanine nucleotide exchange factor Mbc and its target Rac1 function symmetrically in the fusion process. Such models have also inferred that actin foci are also symmetric at the fusion site. Our results demonstrate that the site of fusion is quite asymmetric, however, with respect to these proteins and the process of fusion. We have analyzed Mbc, activated Rac1 and F-actin using a combination of functional analysis and time lapse imaging in the embryo as well as protein localization in primary myoblasts. These studies demonstrate, first, that Mbc is essential in the FCMs but that the founder cells are capable of fusing with FCMs in its absence. Functional studies also show that activated Rac1 in the FCMs rescues the mbc loss of function phenotype, confirming that the role of Mbc is to activate Rac1. Our data further show that Mbc, active Rac1 and F-actin foci are highly enriched, if not exclusive, to the FCMs at their contact sites with founder cells and developing myotubes. We have confirmed the localization of F-actin during fusion by live imaging in embryos. Of note, we also observe Mbc, active Rac1 and Factin in Sns:Kirre associated projections that emanate from the FCMs and appear to push into the myotube. During embryonic development, subsets of cells differentiate into discrete muscle tissues. This process forms tissues that allow the embryo to propel itself, contract the heart muscle to drive blood throughout the organism, and perform other functions necessary for survival. Our project is focused on a specific zebrafish mutant, dead elvis (del), which was discovered through a novel screening methodology in Dr. Lessman's laboratory at the University of Memphis. The dead elvis (del) mutation manifests a non-motile, homozygous phenotype around 20 h after fertilization. The dead elvis mutant has obvious myotome defects and a lack of sarcomere organization. This project involves the genetic mapping and phenotypic characterization of the dead elvis mutation. Using a whole genome screen, we localized the mutation to LG9, and isolated candidate genes. Utilizing immunohistochemistry and confocal microscopy techniques, we have observed muscle formation and sarcomeric assemblage differences in the dead elvis mutant. Further study of this mutation may aid in the understanding of myotome development and lead to more insight into human neuromuscular disease conditions. 
